This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RECTOSIGMOID_JUNCTION_EXALLC for full statistics.
Malignant neoplasm of rectosigmoid junction
C3_RECTOSIGMOID_JUNCTION
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C19&
Cause of death: ICD-9
1540
Cause of death: ICD-8
1540
Cancer registry: Topography ICD-O-3
C19
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
377
Check minimum number of events None
377
Include endpoints None
377
Remove individuals based on genotype QC
359
C3_RECTOSIGMOID_JUNCTION
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of rectosigmoid junction
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of rectosigmoid junction (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 359 | 122 | 237 |
| Unadjusted prevalence (%) | 0.09 | 0.05 | 0.13 |
| Mean age at first event (years) | 67.33 | 64.36 | 68.85 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_RECTOSIGMOID_JUNCTION – Malignant neoplasm of rectosigmoid junction
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of rectosigmoid junction
↥Endpoint not on priority list, no data to show.